高级检索
    黄诚, 林根, 黎扬斯. RAS突变在EML4-ALK阳性肺癌联合治疗中的作用[J]. 循证医学, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
    引用本文: 黄诚, 林根, 黎扬斯. RAS突变在EML4-ALK阳性肺癌联合治疗中的作用[J]. 循证医学, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
    shu
    HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
    Citation: HUANG Cheng, LIN Gen, LI Yang-si. RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(1): 36-40. DOI: 10.12019/j.issn.1671-5144.2016.01.010
    shu

    RAS突变在EML4-ALK阳性肺癌联合治疗中的作用

    RAS Mutation Underlies a Rational Polytherapy Strategy in EML4-ALK-Positive Lung Cancer

      摘要
      • HTML全文
      • 参考文献(10)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回